• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tumor-associated calcium signal transducer 2 (TACSTD2), Truncated

ACP22149

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP22149 Target NameTACSTD2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range27-274Protein LengthExtracellular Domain
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP09758
Background Information
  • Uniprot Id

    P09758

  • Target Species

    Human

  • Target Name

    TACSTD2

  • Target Full Name

    Tumor-associated calcium signal transducer 2

  • Target Function

    May function as a growth factor receptor.

  • Target Involvement

    Corneal dystrophy, gelatinous drop-like (GDLD)

  • Target Subcellular Location

    Membrane; Single-pass type I membrane protein.

  • Target Protein Families

    EPCAM family

  • Target Tissue Specificity

    Placenta, pancreatic carcinoma cell lines.

  • Target Synonyms

    TACSTD2; GA733-1; M1S1; TROP2; Tumor-associated calcium signal transducer 2; Cell surface glycoprotein Trop-2; Membrane component chromosome 1 surface marker 1; Pancreatic carcinoma marker protein GA733-1

  • Target Background

    This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.

Inquire Recombinant Human Tumor-associated calcium signal transducer 2 (TACSTD2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification